APELLIS PHARMACEUTICALS INC's ticker is and the CUSIP is 03753UAB2. A total of 23 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,591,416 | -48.4% | 1,285,000 | 0.0% | 0.00% | -100.0% |
Q2 2023 | $3,084,719 | +29.1% | 1,285,000 | 0.0% | 0.00% | – |
Q1 2023 | $2,389,689 | -37.5% | 1,285,000 | -48.1% | 0.00% | -100.0% |
Q4 2022 | $3,824,630 | -48.9% | 2,476,000 | -35.7% | 0.00% | -50.0% |
Q3 2022 | $7,491,000 | -13.3% | 3,853,000 | -33.4% | 0.00% | 0.0% |
Q2 2022 | $8,639,000 | -9.5% | 5,788,000 | -3.9% | 0.00% | 0.0% |
Q1 2022 | $9,544,000 | +8.4% | 6,025,000 | +3.4% | 0.00% | +100.0% |
Q4 2021 | $8,807,000 | +43.2% | 5,825,000 | +16.2% | 0.00% | 0.0% |
Q3 2021 | $6,151,000 | -25.7% | 5,015,000 | +11.7% | 0.00% | 0.0% |
Q2 2021 | $8,279,000 | +270.9% | 4,490,000 | +182.4% | 0.00% | – |
Q1 2021 | $2,232,000 | -19.4% | 1,590,000 | -3.6% | 0.00% | -100.0% |
Q4 2020 | $2,769,000 | +57.0% | 1,650,000 | 0.0% | 0.00% | – |
Q3 2020 | $1,764,000 | – | 1,650,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DeepCurrents Investment Group LLC | 39,528,000 | $49,938,921 | 2.17% |
LINDEN ADVISORS LP | 15,000,000 | $18,816,676 | 0.19% |
Verition Fund Management LLC | 12,454 | $15,645,338 | 0.18% |
WOLVERINE ASSET MANAGEMENT LLC | 11,766,000 | $14,863,606 | 0.17% |
PALISADE CAPITAL MANAGEMENT, LP | 1,017,000 | $1,284,573 | 0.04% |
LAZARD ASSET MANAGEMENT LLC | 12,242,000 | $15,379 | 0.02% |
KORNITZER CAPITAL MANAGEMENT INC /KS | 300,000 | $371,070 | 0.01% |
D. E. Shaw & Co., Inc. | 5,000,000 | $6,267,238 | 0.01% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
CITIGROUP INC | 504,000 | $623,398 | 0.00% |